Expression of proteinase-activated receptors in mouse microglial cells

Stephanie Balcaitis1, Yiheng Xie, Jonathan R Weinstein

  • 1Department of Neurosurgery, University of Washington, Seattle, 98195, USA.

Neuroreport
|December 10, 2003
PubMed

Insights

Microglia, the brain's immune cells, are activated by substances like thrombin. This study confirms microglia express proteinase-activated receptors (PARs), suggesting PARs as potential therapeutic targets for neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells in the central nervous system (CNS), acting as tissue macrophages.
  • Microglial activation is a rapid response to CNS damage, triggered by substances released from injured brain tissue.
  • Thrombin, a blood coagulation factor entering the CNS during blood-brain barrier breakdown, has been shown to activate microglia.

Purpose of the Study:

  • To investigate the expression of proteinase-activated receptors (PARs) on microglial cells.
  • To determine if PARs mediate the effects of thrombin and other trypsin-like proteases on microglia.
  • To explore the therapeutic potential of targeting PARs in neuroinflammatory disorders.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) was used to detect PAR gene expression.
  • Flow cytometry was employed to confirm PAR protein expression on microglial cells.
  • Primary mouse microglial cells and murine microglial cell lines (BV-2, N9) were utilized.

Main Results:

  • Primary mouse microglia and the BV-2 and N9 cell lines express multiple PARs.
  • The expression levels of PARs varied among the different microglial cell types studied.
  • This confirms that microglia possess the molecular machinery to respond to PAR-activating proteases.

Conclusions:

  • Microglial cells express proteinase-activated receptors (PARs).
  • The presence of PARs on microglia supports their role in sensing CNS damage and inflammation.
  • PARs represent promising therapeutic targets for treating neuroinflammatory conditions.

Related Concept Videos